19 June 2013
Keywords: fda, delays, review, lilly, sepsis, drug, food
Article | 15 June 2001
The US Food and Drug Administration has unexpectedly delayed its reviewof Eli Lilly's sepsis treatment Xigris (drotrecogin alfa; formerly
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 June 2001
14 June 2001
13 June 2001
© 2013 thepharmaletter.com